International safety notice
Ensayo Bilirrubin Direct Gen. 2 (BILD2), referencia 05168384190 y Ensayo C-Reactive Protein Gen. 3 (CRPL3), referencia 05172373190.
Spain / AEMPS · ESP · Nov 17, 2020
Key facts
| Title | Ensayo Bilirrubin Direct Gen. 2 (BILD2), referencia 05168384190 y Ensayo C-Reactive Protein Gen. 3 (CRPL3), referencia 05172373190. |
|---|---|
| Regulator | Spain / AEMPS |
| Country | ESP |
| Brand | Ensayo Bilirrubin Direct Gen. 2 (BILD2), referencia 05168384190 y Ensayo C-Reactive Protein Gen. 3 (CRPL3), referencia 05172373190. |
| Manufacturer | Roche Diagnostics GmbH, Alemania. |
| Models | 05166861190, 2020-626, 31-AGO-2019, 43907901CRPL3, 31-ENE-2021, NOV-2020, 36133801, 28022, BILT3, GEN.2, T30354, 91.822.52.89 and 31 more |
| Event type | Safety Notice |
| Date | Nov 17, 2020 |
At a glance
- No Recall
- Yes Field safety notice
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About International device safety notices
Field safety notices, recalls and safety alerts published by about 30 national medical device regulators outside the United States, matched by Orca1 to FDA device data.
Source: National medical device regulators (as listed), compiled by Orca1